Until about 1975 theophylline was used in this country for the treatment of asthma almost exclusively as intravenous aminophylline. With the introduction of oral preparations theophylline came onto the market to compete with the beta agonists, sodium cromoglycate and beclomethasone. Their introduction was also coincident with the age of the clinical trial-some would say the age of the poor clinical trial-and theophylline has been compared with almost every other drug for asthma in what seems to be every possible permutation. Those who have escaped involvement in the trials will not have escaped the marketing. In this country there are no fewer than five slow release, two liquid, and two tablet preparations suitable for children. As not all are 100% theophylline dosage, when translated into patient oriented language of mls and pills, becomes an exercise of memory and arithmetic.
Does theophylline work?
There is no doubt that theophylline is an efficient bronchodilator, but how it works is unknown. It If the dosage does not produce a therapeutic result-that is, the asthma is not controlled-the clinician has two choices: he can either admit the child for a profile, remembering the difficulties in interpreting such a profile, and increase the dosage if necessary (after which he should logically do another profile) or he can simply change the drug. Patients with severe asthma in whom manipulation of drugs has failed to effect adequate control are the most likely candidates for the 'tailoring' of theophylline dosage. Ideally, this should be done under conditions of diet and activity most resembling those of everyday life.
Side effects
Severe toxicity in children, with convulsions, coma, and haemorrhage, which can clearly be ascribed to theophylline, seems to occur only when the usual dose has been exceeded or when aminophylline has been given in addition.
It is the clinical impression that theophylline, even when concentrations are below 20 ig/ml, is associated with nausea and vomiting. 
